S&P 500   3,853.07
DOW   31,176.01
QQQ   326.36
S&P 500   3,853.07
DOW   31,176.01
QQQ   326.36
S&P 500   3,853.07
DOW   31,176.01
QQQ   326.36
S&P 500   3,853.07
DOW   31,176.01
QQQ   326.36
Log in
NYSE:CLX

The Clorox Stock Forecast, Price & News

$197.21
+0.28 (+0.14 %)
(As of 01/21/2021 12:00 AM ET)
Add
Compare
Today's Range
$196.23
Now: $197.21
$198.29
50-Day Range
$193.73
MA: $200.16
$203.80
52-Week Range
$154.87
Now: $197.21
$239.87
Volume1.22 million shs
Average Volume1.47 million shs
Market Capitalization$24.86 billion
P/E Ratio21.96
Dividend Yield2.25%
Beta0.21
The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The company offers laundry additives, including bleach products under the Clorox brand, as well as Clorox 2 stain fighter and color booster; home care products primarily under the Clorox, Scentiva, Formula 409, Liquid-Plumr, Pine-Sol, S.O.S, and Tilex brands; naturally derived products under the Green Works brand; professional cleaning, disinfecting, and food service products under the CloroxPro, Clorox Healthcare, and Clorox Total 360 brands; professional food service products under the Hidden Valley brand; and vitamins, minerals, and supplement products under the RenewLife, Rainbow Light, Natural Vitality, NeoCell, and Stop Aging Now brands. It also provides grilling products under the Kingsford and Match Light brands; bags and wraps under the Glad brand; and cat litter products under the Fresh Step, Scoop Away, and Ever Clean brands. In addition, the company offers dressings and sauces primarily under the Hidden Valley brand; water-filtration systems and filters under the Brita brand; and natural personal care products under the Burt's Bees brand. Further, it markets its products under the Ayudin, Clorinda, and Poett brands. The company sells its products primarily through mass retailers, grocery outlets, warehouse clubs, dollar stores, home hardware centers, third-party and owned e-commerce channels, military stores, and distributors, as well as a direct sales force. The Clorox Company was founded in 1913 and is headquartered in Oakland, California.
The Clorox logo

MarketRank

Overall MarketRank

2.13 out of 5 stars

Consumer Staples Sector

12th out of 301 stocks

Polishes & Sanitation Goods Industry

1st out of 3 stocks

Analyst Opinion: 2.1Community Rank: 1.5Dividend Strength: 4.2Insider Behavior: 1.7Valuation: 1.3 5 -4 -3 -2 -1 -

Industry, Sector and Symbol

Industry Polishes & sanitation goods
Sub-IndustryHousehold Products
CUSIP18905410
Phone510-271-7000
Employees8,800

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$6.72 billion
Cash Flow$8.85 per share
Book Value$7.19 per share

Profitability

Net Income$939 million

Miscellaneous

Market Cap$24.86 billion
Next Earnings Date2/4/2021 (Confirmed)
OptionableOptionable
$197.21
+0.28 (+0.14 %)
(As of 01/21/2021 12:00 AM ET)
30 days | 90 days | 365 days | Advanced Chart

Receive CLX News and Ratings via Email

Sign-up to receive the latest news and ratings for CLX and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles











The Clorox (NYSE:CLX) Frequently Asked Questions

How has The Clorox's stock been impacted by COVID-19?

The Clorox's stock was trading at $169.40 on March 11th, 2020 when COVID-19 reached pandemic status according to the World Health Organization. Since then, CLX shares have increased by 16.4% and is now trading at $197.21.
View which stocks have been most impacted by COVID-19
.

Is The Clorox a buy right now?

15 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for The Clorox in the last year. There are currently 3 sell ratings, 7 hold ratings and 5 buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "hold" The Clorox stock. A hold rating indicates that analysts believe investors should maintain any existing positions they have in CLX, but not buy additional shares or sell existing shares.
View analyst ratings for The Clorox
or view MarketBeat's top 5 stock picks.

What stocks does MarketBeat like better than The Clorox?

Wall Street analysts have given The Clorox a "Hold" rating, but there may be better short-term opportunities in the market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new trading ideas, but The Clorox wasn't one of them. MarketBeat thinks these five stocks may be even better buys.
View MarketBeat's top stock picks here.

What is Larry J. Merlo's approval rating as The Clorox's CEO?

6,978 employees have rated The Clorox CEO Larry J. Merlo on Glassdoor.com. Larry J. Merlo has an approval rating of 37% among The Clorox's employees. This puts Larry J. Merlo in the bottom 10% of approval ratings compared to other CEOs of publicly-traded companies.

When is The Clorox's next earnings date?

The Clorox is scheduled to release its next quarterly earnings announcement on Thursday, February 4th 2021.
View our earnings forecast for The Clorox
.

How can I listen to The Clorox's earnings call?

The Clorox will be holding an earnings conference call on Thursday, February 4th at 12:00 AM Eastern. Interested parties can register for or listen to the call using this link or dial in at Not Available.

How were The Clorox's earnings last quarter?

The Clorox Company (NYSE:CLX) issued its quarterly earnings results on Saturday, November, 7th. The company reported $3.22 EPS for the quarter, topping analysts' consensus estimates of $2.32 by $0.90. The business had revenue of $1.92 billion for the quarter, compared to the consensus estimate of $1.74 billion. The Clorox had a return on equity of 132.72% and a net margin of 16.14%. The firm's revenue for the quarter was up 27.2% compared to the same quarter last year. During the same period last year, the firm posted $1.59 EPS.
View The Clorox's earnings history
.

How often does The Clorox pay dividends? What is the dividend yield for The Clorox?

The Clorox declared a quarterly dividend on Tuesday, November 17th. Investors of record on Wednesday, January 27th will be given a dividend of $1.11 per share on Friday, February 12th. This represents a $4.44 annualized dividend and a dividend yield of 2.25%. The ex-dividend date of this dividend is Tuesday, January 26th.
View The Clorox's dividend history
.

Is The Clorox a good dividend stock?

The Clorox pays an annual dividend of $4.44 per share and currently has a dividend yield of 2.25%. The Clorox has been increasing its dividend for 45 consecutive years, indicating the company has a strong committment to maintain and grow its dividend. The dividend payout ratio of The Clorox is 60.33%. This payout ratio is at a healthy, sustainable level, below 75%. Based on earnings estimates, The Clorox will have a dividend payout ratio of 55.50% next year. This indicates that The Clorox will be able to sustain or increase its dividend.
View The Clorox's dividend history.

What guidance has The Clorox issued on next quarter's earnings?

The Clorox issued an update on its FY 2021 Pre-Market earnings guidance on Monday, November, 2nd. The company provided earnings per share guidance of 7.70-7.95 for the period, compared to the Thomson Reuters consensus earnings per share estimate of $7.69. The company issued revenue guidance of $7.057-7.326 billion, compared to the consensus revenue estimate of $6.93 billion.

What price target have analysts set for CLX?

15 brokerages have issued 12 month target prices for The Clorox's stock. Their forecasts range from $164.00 to $268.00. On average, they anticipate The Clorox's stock price to reach $216.67 in the next year. This suggests a possible upside of 9.9% from the stock's current price.
View analysts' price targets for The Clorox
or view Wall Street analyst' top-rated stocks.

Who are some of The Clorox's key competitors?

What other stocks do shareholders of The Clorox own?

Based on aggregate information from My MarketBeat watchlists, some companies that other The Clorox investors own include Johnson & Johnson (JNJ), AbbVie (ABBV), NVIDIA (NVDA), Verizon Communications (VZ), AT&T (T), The Walt Disney (DIS), The Home Depot (HD), The Procter & Gamble (PG), Intel (INTC) and JPMorgan Chase & Co. (JPM).

Who are The Clorox's key executives?

The Clorox's management team includes the following people:
  • Mr. Benno O. Dorer, Exec. Chairman (Age 57, Pay $5.36M)
  • Ms. Linda Rendle, CEO & Director (Age 43, Pay $2.2M)
  • Mr. Kevin B. Jacobsen, Exec. VP & CFO (Age 55, Pay $1.78M)
  • Mr. Eric H. Reynolds, Exec. VP & COO (Age 51, Pay $1.77M)
  • Mr. Jeff R. Baker, VP, Chief Accounting Officer & Corp. Controller (Age 52)
  • Ms. Chau Banks, Sr. VP and Chief Information & Enterprise Analytics Officer (Age 52)
  • Lisah Burhan, VP of Investor Relations
  • Ms. Angela C. Hilt, Sr. VP, Corp. Sec. & Chief Legal Officer
  • Ms. Stacey Grier, Sr. VP and Chief Marketing & Strategy Officer (Age 58)
  • Ms. Kirsten M. Marriner, Exec. VP and Chief People & Corp. Affairs Officer (Age 48)

What is The Clorox's stock symbol?

The Clorox trades on the New York Stock Exchange (NYSE) under the ticker symbol "CLX."

Who are The Clorox's major shareholders?

The Clorox's stock is owned by a variety of institutional and retail investors. Top institutional shareholders include State of Alaska Department of Revenue (0.07%), Liberty One Investment Management LLC (0.06%), Fulton Breakefield Broenniman LLC (0.06%), Pinnacle Financial Partners Inc. (0.04%), Investment House LLC (0.04%) and Hexavest Inc. (0.03%). Company insiders that own The Clorox stock include A D David Mackay, Andrew J Mowery, Benno O Dorer, Denise Garner, Diego J Barral, Eric H Reynolds, Jeff Baker, Kevin B Jacobsen, Laura Stein, Matthew T Laszlo, Michael R Costello and William S Bailey.
View institutional ownership trends for The Clorox
.

Which institutional investors are selling The Clorox stock?

CLX stock was sold by a variety of institutional investors in the last quarter, including Hexavest Inc., Fulton Breakefield Broenniman LLC, Donaldson Capital Management LLC, Pacer Advisors Inc., State of Alaska Department of Revenue, Boston Trust Walden Corp, Cypress Capital Group, and Pinnacle Financial Partners Inc.. Company insiders that have sold The Clorox company stock in the last year include Andrew J Mowery, Benno O Dorer, Denise Garner, Diego J Barral, Eric H Reynolds, Jeff Baker, Kevin B Jacobsen, Laura Stein, and William S Bailey.
View insider buying and selling activity for The Clorox
or view top insider-selling stocks.

Which institutional investors are buying The Clorox stock?

CLX stock was bought by a variety of institutional investors in the last quarter, including Central Bank & Trust Co., Liberty Capital Management Inc., Journey Advisory Group LLC, Polianta Ltd, Kestra Advisory Services LLC, Patriot Financial Group Insurance Agency LLC, Global Trust Asset Management LLC, and NuWave Investment Management LLC.
View insider buying and selling activity for The Clorox
or or view top insider-buying stocks.

How do I buy shares of The Clorox?

Shares of CLX can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is The Clorox's stock price today?

One share of CLX stock can currently be purchased for approximately $197.21.

How big of a company is The Clorox?

The Clorox has a market capitalization of $24.86 billion and generates $6.72 billion in revenue each year. The company earns $939 million in net income (profit) each year or $7.36 on an earnings per share basis. The Clorox employs 8,800 workers across the globe.

What is The Clorox's official website?

The official website for The Clorox is www.thecloroxcompany.com.

How can I contact The Clorox?

The Clorox's mailing address is 1221 BROADWAY, OAKLAND CA, 94612. The company can be reached via phone at 510-271-7000 or via email at [email protected]

This page was last updated on 1/22/2021 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.